Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Lepu Medical Technology Beijing Co Ltd
Total Receivables
Lepu Medical Technology Beijing Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Receivables
¥2.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Receivables
¥50.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Receivables
¥1.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Receivables
¥3.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Total Receivables
¥172.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Receivables
¥3.7B
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lepu Medical Technology Beijing Co Ltd
Glance View
Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.
See Also
What is Lepu Medical Technology Beijing Co Ltd's Total Receivables?
Total Receivables
2.3B
CNY
Based on the financial report for Sep 30, 2024, Lepu Medical Technology Beijing Co Ltd's Total Receivables amounts to 2.3B CNY.
What is Lepu Medical Technology Beijing Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
9%
Over the last year, the Total Receivables growth was 9%. The average annual Total Receivables growth rates for Lepu Medical Technology Beijing Co Ltd have been -3% over the past three years , -4% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet